Background <p>Febrile ulceronecrotic Mucha–Habermann Disease (FUMHD) is a rare and severe form of pityriasis lichenoides et varioliformis acuta. It presents rapidly with ulcerative and necrotic lesions, fever, and systemic symptoms. This condition is associated with significant morbidity and can be extremely dangerous. The exact cause of FUMHD is not well understood, but hypersensitivity reactions may trigger it.</p> Case presentation <p>We describe a 15-month-old Iranian boy who developed rapidly progressing ulceronecrotic skin lesions accompanied by high-grade fever and systemic involvement. A skin biopsy confirmed a diagnosis of FUMHD. Despite treatment with methylprednisolone, intravenous immunoglobulin, and a TNF-α inhibitor, the disease was fatal. To our knowledge, this represents the third reported fatal case of FUMHD in children and the youngest case documented to date.</p> Conclusion <p>This report presents the youngest known pediatric case of fatal FUMHD, highlighting the challenges of early diagnosis, risk of systemic infection, and limited treatment options. Early immunosuppressive and antimicrobial therapies are crucial, but prognosis remains poor in aggressive cases.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

A fatal pediatric case of febrile ulceronecrotic Mucha–Habermann disease: diagnostic and therapeutic challenges: a case report

  • Soheila Alyasin,
  • Zahra Kanannejad,
  • Alireza Abbasi,
  • Mohammad Javad Entezari,
  • Sara Alavizadeh,
  • Leila johari

摘要

Background

Febrile ulceronecrotic Mucha–Habermann Disease (FUMHD) is a rare and severe form of pityriasis lichenoides et varioliformis acuta. It presents rapidly with ulcerative and necrotic lesions, fever, and systemic symptoms. This condition is associated with significant morbidity and can be extremely dangerous. The exact cause of FUMHD is not well understood, but hypersensitivity reactions may trigger it.

Case presentation

We describe a 15-month-old Iranian boy who developed rapidly progressing ulceronecrotic skin lesions accompanied by high-grade fever and systemic involvement. A skin biopsy confirmed a diagnosis of FUMHD. Despite treatment with methylprednisolone, intravenous immunoglobulin, and a TNF-α inhibitor, the disease was fatal. To our knowledge, this represents the third reported fatal case of FUMHD in children and the youngest case documented to date.

Conclusion

This report presents the youngest known pediatric case of fatal FUMHD, highlighting the challenges of early diagnosis, risk of systemic infection, and limited treatment options. Early immunosuppressive and antimicrobial therapies are crucial, but prognosis remains poor in aggressive cases.